RCT of Mobile Apps & FitBit v. Usual Care
Reason given: Study is paused for interim analysis.
Key facts
- Where
- New York, United StatesSee the site
Where in United States
- Weill Cornell Medicine | New York-PresbyterianNew York, United StatesNo longer taking part
Trial details
- Who runs it
- Weill Medical College of Cornell University
- Trial code
- NCT03623464
- Record updated
- 28 September 2026
- Original description
This is a randomized clinical trial to evaluate the use of mobile devices in preventing readmission in patients undergoing major GI cancer operations.Read full original descriptionShow less
Randomized Clinical Trial of FitBit and Mobile Apps Versus Usual Care to Improve Post-Operative Outcomes After GI Cancer Surgery
This is a randomized clinical trial to evaluate the use of mobile devices in preventing readmission in patients undergoing major GI cancer operations.
Inclusion: Subject is 18 years or older; Subject speaks English; Subject owns a smart phone; Subject is scheduled to undergo surgery for a GI cancer (pancreatic, hepatic, gastric, small bowel, colon, or rectal cancers).
Exclusion: Subject is undergoing emergent surgery; Physician deems the subject is unable to complete the study due to documented alcohol and/or drug abuse; Physician deems the subject is unable to complete the study due to documented dementia; Subject has sepsis from another source.